标题
Neuroblastoma—A Neural Crest Derived Embryonal Malignancy
作者
关键词
-
出版物
Frontiers in Molecular Neuroscience
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-01-29
DOI
10.3389/fnmol.2019.00009
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Sense-Antisense lncRNA Pair Encoded by Locus 6p22.3 Determines Neuroblastoma Susceptibility via the USP36-CHD7-SOX9 Regulatory Axis
- (2018) Tanmoy Mondal et al. CANCER CELL
- Spontaneous regression of neuroblastoma
- (2018) Garrett M. Brodeur CELL AND TISSUE RESEARCH
- Molecular mechanisms and therapeutic targets in neuroblastoma
- (2018) John Inge Johnsen et al. PHARMACOLOGICAL RESEARCH
- The Expanding World of N-MYC–Driven Tumors
- (2018) David S. Rickman et al. Cancer Discovery
- Patient-derived xenograft models reveal intratumor heterogeneity and temporal stability in neuroblastoma
- (2018) Noémie Braekeveldt et al. CANCER RESEARCH
- Fine mapping of 2q35 high-risk neuroblastoma locus reveals independent functional risk variants and suggests full-length BARD1 as tumor-suppressor
- (2018) Flora Cimmino et al. INTERNATIONAL JOURNAL OF CANCER
- From Neural Crest Development to Cancer and Vice Versa: How p75NTR and (Pro)neurotrophins Could Act on Cell Migration and Invasion?
- (2018) Sabine Wislet et al. Frontiers in Molecular Neuroscience
- Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project
- (2017) Lucas Moreno et al. Expert Opinion on Drug Discovery
- Advances in emerging drugs for the treatment of neuroblastoma
- (2017) Pablo Berlanga et al. EXPERT OPINION ON EMERGING DRUGS
- Overview and recent advances in the treatment of neuroblastoma
- (2017) Sarah B. Whittle et al. Expert Review of Anticancer Therapy
- Irinotecan–temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial
- (2017) Rajen Mody et al. LANCET ONCOLOGY
- Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial
- (2017) Ruth Ladenstein et al. LANCET ONCOLOGY
- MYCN induces neuroblastoma in primary neural crest cells
- (2017) R R Olsen et al. ONCOGENE
- Rho-associated kinase is a therapeutic target in neuroblastoma
- (2017) Cecilia Dyberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neuroblastoma
- (2017) Jason Shohet et al. BMJ-British Medical Journal
- Neuroblastoma
- (2017) Jason Shohet et al. BMJ-British Medical Journal
- Dualistic Role of BARD1 in Cancer
- (2017) Flora Cimmino et al. Genes
- The role of the ALK receptor in cancer biology
- (2016) B. Hallberg et al. ANNALS OF ONCOLOGY
- Slit-Robo signaling
- (2016) Heike Blockus et al. DEVELOPMENT
- The SWI/SNF BAF-A complex is essential for neural crest development
- (2016) Ronald L. Chandler et al. DEVELOPMENTAL BIOLOGY
- Neuroblastoma
- (2016) Katherine K. Matthay et al. Nature Reviews Disease Primers
- Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations
- (2015) Kristopher R. Bosse et al. CANCER
- A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis
- (2015) Robert W. Schnepp et al. CANCER CELL
- CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus
- (2015) M. R. Russell et al. CANCER RESEARCH
- Telomerase activation by genomic rearrangements in high-risk neuroblastoma
- (2015) Martin Peifer et al. NATURE
- Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism
- (2015) Derek A. Oldridge et al. NATURE
- Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
- (2015) Thomas F Eleveld et al. NATURE GENETICS
- Mutational dynamics between primary and relapse neuroblastomas
- (2015) Alexander Schramm et al. NATURE GENETICS
- TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors
- (2015) Linda J Valentijn et al. NATURE GENETICS
- Neuroblastoma
- (2015) Meredith S. Irwin et al. PEDIATRIC CLINICS OF NORTH AMERICA
- Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma
- (2015) Alex Cazes et al. Oncotarget
- Genotype-phenotype correlation of Coffin-Siris syndrome caused by mutations inSMARCB1,SMARCA4,SMARCE1, andARID1A
- (2014) Tomoki Kosho et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS
- The Risk-Associated Long Noncoding RNA NBAT-1 Controls Neuroblastoma Progression by Regulating Cell Proliferation and Neuronal Differentiation
- (2014) Gaurav Kumar Pandey et al. CANCER CELL
- ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma
- (2014) Scott C. Bresler et al. CANCER CELL
- Common Genetic Variants in NEFL Influence Gene Expression and Neuroblastoma Risk
- (2014) M. Capasso et al. CANCER RESEARCH
- Insight into planar cell polarity
- (2014) Michael Sebbagh et al. EXPERIMENTAL CELL RESEARCH
- Metastatic Neuroblastoma Confined to Distant Lymph Nodes (stage 4N) Predicts Outcome in Patients With Stage 4 Disease: A Study From the International Neuroblastoma Risk Group Database
- (2014) Daniel A. Morgenstern et al. JOURNAL OF CLINICAL ONCOLOGY
- Emergence of New ALK Mutations at Relapse of Neuroblastoma
- (2014) Gudrun Schleiermacher et al. JOURNAL OF CLINICAL ONCOLOGY
- Mechanisms of neuroblastoma regression
- (2014) Garrett M. Brodeur et al. Nature Reviews Clinical Oncology
- Genomic organization and evolution of double minutes/homogeneously staining regions withMYCamplification in human cancer
- (2014) Alberto L'Abbate et al. NUCLEIC ACIDS RESEARCH
- A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies
- (2014) K Althoff et al. ONCOGENE
- Suppression of Cpn10 Increases Mitochondrial Fission and Dysfunction in Neuroblastoma Cells
- (2014) So Jung Park et al. PLoS One
- Ch14.18 antibody produced in CHO cells in relapsed or refractory Stage 4 neuroblastoma patients
- (2013) Ruth Ladenstein et al. mAbs
- The genetic landscape of high-risk neuroblastoma
- (2013) Trevor J Pugh et al. NATURE GENETICS
- Long-term results of the combination of the N7 induction chemotherapy and the busulfan-melphalan high dose chemotherapy
- (2013) Dominique Valteau-Couanet et al. PEDIATRIC BLOOD & CANCER
- Boundary formation in the development of the vertebrate hindbrain
- (2013) Qiling Xu et al. Wiley Interdisciplinary Reviews-Developmental Biology
- The ALKF1174L Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma
- (2012) Teeara Berry et al. CANCER CELL
- Activated ALK Collaborates with MYCN in Neuroblastoma Pathogenesis
- (2012) Shizhen Zhu et al. CANCER CELL
- Common Variation at BARD1 Results in the Expression of an Oncogenic Isoform That Influences Neuroblastoma Susceptibility and Oncogenicity
- (2012) K. R. Bosse et al. CANCER RESEARCH
- Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility
- (2012) Mario Capasso et al. CARCINOGENESIS
- Association of Age at Diagnosis and Genetic Mutations in Patients With Neuroblastoma
- (2012) Nai-Kong V. Cheung JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Melanoma genome sequencing reveals frequent PREX2 mutations
- (2012) Michael F. Berger et al. NATURE
- Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
- (2012) Jan J. Molenaar et al. NATURE
- Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma
- (2012) Sharon J Diskin et al. NATURE GENETICS
- Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
- (2012) Michael Krauthammer et al. NATURE GENETICS
- Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma
- (2012) Mark Sausen et al. NATURE GENETICS
- Essential Roles of Gangliosides in the Formation and Maintenance of Membrane Microdomains in Brain Tissues
- (2012) Yuhsuke Ohmi et al. NEUROCHEMICAL RESEARCH
- Tumor Development, Growth Characteristics and Spectrum of Genetic Aberrations in the TH-MYCN Mouse Model of Neuroblastoma
- (2012) Agnes Rasmuson et al. PLoS One
- Targeted Expression of Mutated ALK Induces Neuroblastoma in Transgenic Mice
- (2012) L. C. Heukamp et al. Science Translational Medicine
- Rare Copy Number Variations in Adults with Tetralogy of Fallot Implicate Novel Risk Gene Pathways
- (2012) Candice K. Silversides et al. PLoS Genetics
- Expression of GD2 and GD3 Gangliosides in Human Embryonic Neural Stem Cells
- (2011) Makoto Yanagisawa et al. ASN Neuro
- The Neuronal Differentiation Factor NeuroD1 Downregulates the Neuronal Repellent Factor Slit2 Expression and Promotes Cell Motility and Tumor Formation of Neuroblastoma
- (2011) P. Huang et al. CANCER RESEARCH
- Lin28A and Lin28B Inhibit let-7 MicroRNA Biogenesis by Distinct Mechanisms
- (2011) Elena Piskounova et al. CELL
- Midkine and Alk signaling in sympathetic neuron proliferation and neuroblastoma predisposition
- (2011) T. Reiff et al. DEVELOPMENT
- Transcriptional control of differentiation and neurogenesis in autonomic ganglia
- (2011) Hermann Rohrer EUROPEAN JOURNAL OF NEUROSCIENCE
- Neuroblastoma: Biology, Prognosis, and Treatment
- (2010) Julie R. Park et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Neuroblastoma Phox2b Variants Stimulate Proliferation and Dedifferentiation of Immature Sympathetic Neurons
- (2010) T. Reiff et al. JOURNAL OF NEUROSCIENCE
- Integrative genomics identifies LMO1 as a neuroblastoma oncogene
- (2010) Kai Wang et al. NATURE
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
- (2010) Alice L. Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recent Advances in Neuroblastoma
- (2010) John M. Maris NEW ENGLAND JOURNAL OF MEDICINE
- High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset
- (2010) H. Caren et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure and function of SWI/SNF chromatin remodeling complexes and mechanistic implications for transcription
- (2010) Liling Tang et al. PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY
- Embryonal neural tumours and cell death
- (2009) John Inge Johnsen et al. APOPTOSIS
- Anaplastic lymphoma kinase: signalling in development and disease
- (2009) Ruth H. Palmer et al. BIOCHEMICAL JOURNAL
- International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee
- (2009) P F Ambros et al. BRITISH JOURNAL OF CANCER
- Rho-kinase inhibitors as therapeutics: from pan inhibition to isoform selectivity
- (2009) C. Hahmann et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- On Trk--The TrkB Signal Transduction Pathway Is an Increasingly Important Target in Cancer Biology
- (2009) C. J. Thiele et al. CLINICAL CANCER RESEARCH
- Trk Receptor Expression and Inhibition in Neuroblastomas
- (2009) G. M. Brodeur et al. CLINICAL CANCER RESEARCH
- Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study
- (2009) Katherine K. Matthay et al. JOURNAL OF CLINICAL ONCOLOGY
- Copy number variation at 1q21.1 associated with neuroblastoma
- (2009) Sharon J. Diskin et al. NATURE
- Common variations in BARD1 influence susceptibility to high-risk neuroblastoma
- (2009) Mario Capasso et al. NATURE GENETICS
- The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report
- (2008) Tom Monclair et al. JOURNAL OF CLINICAL ONCOLOGY
- High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial
- (2008) Andrew DJ Pearson et al. LANCET ONCOLOGY
- Identification of ALK as a major familial neuroblastoma predisposition gene
- (2008) Yaël P. Mossé et al. NATURE
- A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment
- (2008) Agnieszka Rybak et al. NATURE CELL BIOLOGY
- Chromosome 6p22 Locus Associated with Clinically Aggressive Neuroblastoma
- (2008) John M. Maris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing
- (2008) M. A. Newman et al. RNA
- Selective Blockade of MicroRNA Processing by Lin28
- (2008) S. R. Viswanathan et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started